FDA fast-tracks approval for Alzheimer's drug
The Food and Drug Administration approved a new Alzheimer's drug called Leqembi, that has been shown to slow the decline in memory and thinking. The medication costs more than $26,000 per year.
No comments have been added yet.
Larry E. Swedroe's Blog
- Larry E. Swedroe's profile
- 46 followers
Larry E. Swedroe isn't a Goodreads Author
(yet),
but they
do have a blog,
so here are some recent posts imported from
their feed.
